Literature DB >> 6786610

Dangers of amiodarone and anticoagulant treatment.

A Rees, J J Dalal, P G Reid, A H Henderson, M J Lewis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6786610      PMCID： PMC1505759          DOI： 10.1136/bmj.282.6278.1756-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  Pharmacology of amiodarone, and anti-anginal drug with a new biological profile.

Authors:  R Charlier; G Deltour; A Baudine; F Chaillet
Journal:  Arzneimittelforschung       Date:  1968-11

2.  The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

3.  Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.

Authors:  E Rowland; D M Krikler
Journal:  Br Heart J       Date:  1980-07
  3 in total
  19 in total

Review 1.  Potentially significant drug interactions of class III antiarrhythmic drugs.

Authors:  Weeranuj Yamreudeewong; Michael DeBisschop; Linda G Martin; Dennis L Lower
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Investigation of patients with abnormal response to warfarin.

Authors:  D P Bentley; G Backhouse; A Hutchings; R L Haddon; B Spragg; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

3.  In vitro amiodarone protein binding and its interaction with warfarin.

Authors:  P Neyroz; M Bonati
Journal:  Experientia       Date:  1985-03-15

4.  Insidiously evolving, occult drug interaction involving warfarin and amiodarone.

Authors:  B Cheung; F M Lam; C R Kumana
Journal:  BMJ       Date:  1996-01-13

Review 5.  Drug interactions with warfarin.

Authors:  M J Serlin; A M Breckenridge
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

6.  Alveolitis after treatment with amiodarone.

Authors:  S A Riley; S E Williams; N J Cooke
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-16

7.  The potentiation of acenocoumarol anticoagulant effect by amiodarone.

Authors:  M Arboix; M E Frati; J R Laporte
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

8.  Prospective study of the potentiation of acenocoumarol by amiodarone.

Authors:  C Richard; B Riou; A Berdeaux; C Fournier; D Khayat; A Rimailho; J F Giudicelli; P Auzépy
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 9.  Clinical pharmacokinetics of amiodarone.

Authors:  R Latini; G Tognoni; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 10.  Clinical pharmacokinetics of the newer antiarrhythmic agents.

Authors:  A M Gillis; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.